NEW YORK, NY — (Marketwire) — 06/05/12 — TriMarkPublications.com cites in its newly published “Global Markets” report that the global market will jump to $4.9 billion by 2017. For more information, visit: .
can be categorized into three main types of applications: research, clinical diagnostic and pharmaceutical. The U.S., Europe and Japan account for 86% of the global market, but the emerging BRIC (Brazil, Russia, India and China) countries- share of the market is rapidly growing at a CAGR of 20%. Combined, the BD Biosciences division of Becton Dickinson and Beckman Coulter account for 49% of the market.
The “Global Markets” report covers:
CD4 T-Cell Testing
Multiplex Bead Assays
Stem Cell Research
Immunophenotyping of Leukemias and Lymphomas
Minimum Residual Disease (MRD)
Platelet Associated Immunoglobulin Assays
Paroxysmal Nocturnal Hemoblobinuria
The “Global Markets” report examines companies manufacturing equipment and supplies in the world. Companies covered include: AbD Serotec, ALPCO, Apogee Flow, Bay, BD, Beckman Coulter, BioCytex, Bioscience, BioVision, Blue Ocean, Cell Signaling, Cira Discovery, Clarient, Cytobank, CytonomeST, DVS, EMD Millipore, iCyt Mission, IntelliCyt, Life Technologies, Luminex, Miltenyi, Mindray, MiraiBio, Nihon Kohden, Partec, PointCare, Promega, Santa Cruzhnology, Sigma-Aldrich, Soft Flow, SouthernBiotech, Stratedigm, Sysmex, Takara, Techne, Tree Star, TTP LabTech, Union Biometrica, U.S. Biological, and Verity Software House.
Detailed charts with sales forecasts and marketshare data are included. For more information, visit: .
TriMarkPublications.com is a global leader in the biotechnology, healthcare and life sciences market research publishing. For more information, please visit .
The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.
TriMarkPublications.com
Media Relations
1-888-OK-TRIMARK